MedTrace Logo

Recrudescence of Eating Conduct Disorders and Covid-19

NCT05780242 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-01-29

No results posted yet for this study

Summary

This qualitative study, combining psychiatric and anthropological perspectives, focused on the development and/or worsening of patients' eating disorders since Covid-19, as well as the experiences and perceptions of those around them - such as their family, teachers or staff. School and nursing staff. This multi-site approach will provide a multidimensional perspective on the experience of individuals and those around them, as well as a triangulation of data. The hypotheses to explain the increase in Eating Disorders (EDs) will be addressed through semi-structured interviews offered to study participants.

Conditions

  • Psychiatric Disorder
  • Eating Disorders in Adolescence
  • COVID-19

Interventions

BEHAVIORAL

Self-questionnaire Eating Attitudes

self-diagnostic and quantitative questionnaire of 40 questions evaluating the behavior, severity and evolution of anorexia nervosa

BEHAVIORAL

Situational Anxiety and Trait Anxiety

assess anxiety as a "personality trait" (feelings of apprehension, tension, nervousness and worry that the subject usually feels), and anxiety as a ' "emotional state" linked to a particular situation

BEHAVIORAL

Beck Depression Inventory (BDI) scale

a diagnostic self-questionnaire allowing a quantitative estimation of the intensity of depressive symptoms in adults and adolescents

BEHAVIORAL

• Post-traumatic Check List Scale

questionnaire includes 20 items, each question is to be rated between 1 and 5 depending on the intensity and frequency of symptoms during the previous month.

Sponsors & Collaborators

  • Fondation Lenval

    lead OTHER

Principal Investigators

  • Louise-Emilie DUMAS, MD · Fondation Lenval

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-12
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05780242 on ClinicalTrials.gov